Global Health Now featured a commentary from GHTC Director Jamie Bay Nishi which makes the case for why the US Agency for International Development should be funded to play a larger role in the research response to COVID-19.
View
GHTC submitted written testimony to the Senate Labor, Health and Human Services (LHHS) Appropriations Subcommittee urging them to sustain and protect global health R&D funding in the fiscal year 2020 (FY21) budget.
PDF
GHTC endorsed a sign-on letter from the Infectious Diseases Society of America (ISDA) urging the US government to engage with the Access to COVID-19 Tools Accelerator (ACT Accelerator), a global initiative designed to drive the development and availability of COVID-19 vaccines.
PDF
POZ quoted a GHTC tweet in an article on HIV Vaccine Awareness Day 2020.
View
GHTC signed on to letters from the tuberculosis (TB) advocacy community urging Congressional appropriators to provide additional resources for US TB programs in the next COVID-19 response legislation to reduce the detrimental impact of the pandemic on these programs.
Learn more
The Global Health Technologies Coalition issued the following statement in advance of the 73rd World Health Assembly, which will be held virtually May 18–19.
Learn more
GHTC condemns President Trump’s fiscal year 2021 budget request seeking deep cuts to global health and medical research programs. The budget proposes a 34 percent cut to global health programs at the US Agency for International Development and the State Department, as well as significant cuts to public health and research agencies within the Department of Health and Human Services.
Learn More
Statement from Jamie Bay Nishi, Director of the Global Health Technologies Coalition, on the passage of the End Neglected Tropical Diseases Act, which was included in H.R. 1865, the Further Consolidated Appropriations Act, 2020, passed by Congress on December 19, 2019.
Learn More
GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”
PDF
POZ quoted a GHTC tweet in an article on HIV Vaccine Awareness Day 2020.
View
Global Health Now featured a commentary from GHTC Director Jamie Bay Nishi which makes the case for why the US Agency for International Development should be funded to play a larger role in the research response to COVID-19.
View
GHTC was mentioned in a press release pickup in the Chinook Observer covering the launch of the Pandemic Action Network, a group of international organizations including GHTC devoted to advancing advocacy to accelerate an end to COVID-19.
View
GHTC director Jamie Bay Nishi appeared on an episode of TRTWorld's Roundup show discussing COVID-19 R&D and the need for multilateral coordination for a global response to the pandemic.
View
GHTC submitted written testimony to the Senate Labor, Health and Human Services (LHHS) Appropriations Subcommittee urging them to sustain and protect global health R&D funding in the fiscal year 2020 (FY21) budget.
PDF
GHTC signed on to letters from the tuberculosis (TB) advocacy community urging Congressional appropriators to provide additional resources for US TB programs in the next COVID-19 response legislation to reduce the detrimental impact of the pandemic on these programs.
Learn more
GHTC joined the Global Health Council (GHC) in urging Congress to provide additional funding to support COVID-19 response efforts in low- and middle-income countries. GHC sent a letter to appropriators signed by GHTC and other partners outlining a top-line ask for global health needs. A detailed supplement shared with the letter included specific recommendations from the global health community, including those from GHTC.
Learn more
GHTC signed on to an open letter from global health advocates urging the Trump Administration to reverse its funding freeze to the World Health Organization (WHO). The letter underscores the vital role WHO is playing in advancing vaccines and other health technologies to combat COVID-19.
PDF
Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
(202) 540-4414
mchmiola@ghtcoalition.org